drugset / Trial / NCT05700097
Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the Efficacy and Safety of Dengzhanxixin Injection in Patients With Acute Ischemic Stroke Receiving Reperfusion Therapy.
Timeline
- Start
- 2022-09-30
- Primary completion
- 2023-09-30
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dengzhanxixin Injection | Unknown | 40 ml | Intravenous |
| Subject | Dengzhanxixin Injection | Unknown | 80 ml | Intravenous |